chrX-17375909-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001291867.2(NHS):c.152C>T(p.Ala51Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000895 in 1,094,804 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001291867.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.152C>T | p.Ala51Val | missense_variant | 1/9 | ENST00000676302.1 | |
NHS | NM_198270.4 | c.152C>T | p.Ala51Val | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.152C>T | p.Ala51Val | missense_variant | 1/9 | NM_001291867.2 | P4 | ||
NHS | ENST00000380060.7 | c.152C>T | p.Ala51Val | missense_variant | 1/8 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111563Hom.: 0 Cov.: 23 AF XY: 0.0000588 AC XY: 2AN XY: 34013
GnomAD3 exomes AF: 0.000154 AC: 7AN: 45459Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 12783
GnomAD4 exome AF: 0.0000946 AC: 93AN: 983241Hom.: 0 Cov.: 32 AF XY: 0.000101 AC XY: 32AN XY: 315437
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111563Hom.: 0 Cov.: 23 AF XY: 0.0000588 AC XY: 2AN XY: 34013
ClinVar
Submissions by phenotype
Nance-Horan syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 13, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 51 of the NHS protein (p.Ala51Val). This variant is present in population databases (rs727504039, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with NHS-related conditions. ClinVar contains an entry for this variant (Variation ID: 167351). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 16, 2016 | - - |
Nance-Horan syndrome;C4049004:Cataract 40 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at